Desmopressin therapy for massive hemoptysis associated with severe leptospirosis.

Am J Respir Crit Care Med

Critical Care and Clinical Biology Units, Centre Hospitalier Territorial, Papeete, Tahiti.

Published: March 2003

Massive hemoptysis in patients with severe leptospirosis is often resistant to conventional therapies and can rapidly become fatal. Desmopressin is a fast-acting blood-saving agent used in various hereditary and acquired clotting disorders. We used desmopressin infusions to treat massive pulmonary hemorrhage in six leptospirosis patients with respiratory failure, shock, and multiple organ dysfunction. Hemoptysis ceased rapidly in every case, and five patients finally recovered. Two additional patients with less severe hemoptysis were also successfully treated.

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.200205-450CRDOI Listing

Publication Analysis

Top Keywords

massive hemoptysis
8
severe leptospirosis
8
patients severe
8
desmopressin therapy
4
therapy massive
4
hemoptysis
4
hemoptysis associated
4
associated severe
4
leptospirosis massive
4
patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!